Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

EuroIntervention 2016;12:e550-e556 published online ahead of print September 2015 published online e-edition August 2016. DOI: 10.4244/EIJY15M09_10

Tommaso Gori
Tommaso Gori1*, MD; Jens Wiebe2, MD; Davide Capodanno3, MD; Azeem Latib4, MD; Maciej Lesiak5, MD; Stylianos A. Pyxaras6, MD; Julinda Mehilli7, MD; Giuseppe Caramanno8, MD; Carlo Di Mario9, MD; Salvatore Brugaletta10, MD; Julia Weber1; Piera Capranzano3, MD; Manel Sabate10, MD; Alessio Mattesini9, MD; Salvatore Geraci8, MD; Christoph K. Naber6, MD; Aleksander Araszkiewicz5, MD; Antonio Colombo4, MD; Corrado Tamburino3, MD; Holg
1. 2. Medizinische Klinik und Poliklinik, Universitätsmedizin Mainz, University Medical Center, Mainz and DZHK Rhein-Main, Germany; 2. Medizinische Klinik I, Department of Cardiology, University of Giessen, Giessen, Germany; 3. Ferrarotto Hospital, Univer

Aims: We aimed to investigate the outcomes of bioresorbable vascular scaffolds (BVS) in coronary ostial lesions. Ostial lesions represent a challenging angiographic subset, with higher ev

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bioresorbable vascular scaffoldcoronary artery diseaseostial lesions
Coronary interventionsInterventions for strokeStents and scaffoldsCarotid stentingStents, devices and techniques
Read next article
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria

Latest news